Learning about Abinet Aklilu’s many research projects today at noon conference, including all of her work on implementation and outcomes of 🚨clinical alerts 🚨 for AKI from within CTRA here at Yale Internal Medicine!!
Great work 👏

Core Curriculum by Namrata Krishnan, Dennis Moledina, MD PhD, and Mark Perazella:

Toxic Nephropathies of the Tubulointerstitium
buff.ly/42uMDwM (FREE)

Yale Nephrology

Would Yale Neph fellowship be Yale Neph fellowship without a few classic fellows teaching sessions by Dr. P? We hope to never find out. Retired Dr. Mark Perazella returning virtually from Florida to give his Renal Pharmacology lecture to the fellows! We are so lucky!

Researchers in Yale Nephrology found that adults with COVID-19 who develop AKI have a lower risk of kidney disease progression & mortality over the longer term compared to those with AKI related to other causes.

Abinet Aklilu F. Perry Wilson, MD MSCE Dennis Moledina, MD PhD
medicine.yale.edu/internal-medic…

Core Curriculum by Namrata Krishnan, Dennis Moledina, MD PhD, and Mark Perazella:

Toxic Nephropathies of the Tubulointerstitium
buff.ly/42uMDwM (FREE)

Yale Nephrology

January Highlights: International Variability in the Epidemiology, Management, and Outcomes of CKD and ESKD: A Systematic Review

This study shows the delivery of kidney care related to ESKD varies widely among countries bit.ly/KID0335

⬇️ Learn more about the Kidney360 Editorial Training Program from the perspective of the program’s trainees, including our own Abinet Aklilu !

#Congratulations to YSM's E. Jennifer Edelman, MD, Madhav and F. Perry Wilson, MD MSCE, who are among 100 #newmembers elected to @the_ASCI. They will be officially #inducted in April.

brnw.ch/21wFu3c

🚨We got him on Twitter!! 🚨
At long last, find him at Mark Perazella!
All credit for this major feat goes to Megan Baker and Deepthi Gunasekaran

The most bittersweet farewell celebration last night Union League Café honoring the truly legendary Dr. Mark Perazella, retiring at the end of 2023. Words cannot express our eternal gratitude and how severely you will be missed as an unparalleled friend, mentor, and physician.

In patients with a high pre-test probability of ADPKD, additional evaluation of cystic gene VUS can be helpful. This Review proposes an algorithm for the assessment of such variants in a clinical setting bit.ly/KID0298

Neera Dahl Abinet Aklilu Mayo Clinic Nephrology

ADPKD has high allelic heterogeneity; no one variant is present in >2% of families. In a case-based review in ASN Kidney360, Abinet Aklilu & Neera Dahl propose an algorithm to eval cystic gene VUS clinically & reassign to a diagnostic grouping. Great pics!

journals.lww.com/kidney360/abst…